Literature DB >> 18384748

GABA and synaptic inhibition of mouse cerebellum lacking glutamate decarboxylase 67.

Kunihiko Obata1, Moritoshi Hirono, Nobuko Kume, Yoshiya Kawaguchi, Shigeyoshi Itohara, Yuchio Yanagawa.   

Abstract

gamma-Aminobutyric acid (GABA) is a major inhibitory neurotransmitter and also presumed to be a neurotrophic factor. GABA is synthesized by glutamate decarboxylase (GAD). A mouse lacking a 67kDa isoform of GAD (GAD67) has a reduced GABA level in its brain at birth and does not survive postnatally because of cleft palate. In this study, to investigate the functional and developmental roles of GABA in the postnatal cerebellum, selective GAD67 deletion was achieved using a Cre-loxP strategy. In this mouse, GABA level was reduced to 16-44% in the cerebellum but not in the cerebrum. Inhibitory synaptic transmission to Purkinje cells was seriously impaired. However, the morphology of Purkinje cells and the density of synaptic terminals in the cerebellar cortex appeared unaffected, suggesting that GABA does not participate in cerebellar development substantially.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384748     DOI: 10.1016/j.bbrc.2008.03.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Activity-dependent regulation of inhibition via GAD67.

Authors:  C Geoffrey Lau; Venkatesh N Murthy
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Gad1 mRNA as a reliable indicator of altered GABA release from orexigenic neurons in the hypothalamus.

Authors:  Matthew S Dicken; Alexander R Hughes; Shane T Hentges
Journal:  Eur J Neurosci       Date:  2015-10-19       Impact factor: 3.386

3.  Neuroscience: The highs and lows of memory.

Authors:  Kevin Allen; Hannah Monyer
Journal:  Nature       Date:  2013-12-12       Impact factor: 49.962

4.  Glutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related Phenotypes.

Authors:  Kazuyuki Fujihara; Hideki Miwa; Toshikazu Kakizaki; Ryosuke Kaneko; Masahiko Mikuni; Chiyoko Tanahira; Nobuaki Tamamaki; Yuchio Yanagawa
Journal:  Neuropsychopharmacology       Date:  2015-04-23       Impact factor: 7.853

5.  Reassessing the Role of Histaminergic Tuberomammillary Neurons in Arousal Control.

Authors:  Anne Venner; Takatoshi Mochizuki; Roberto De Luca; Christelle Anaclet; Thomas E Scammell; Clifford B Saper; Elda Arrigoni; Patrick M Fuller
Journal:  J Neurosci       Date:  2019-09-23       Impact factor: 6.167

6.  Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.

Authors:  Danko Georgiev; Toru Yoshihara; Rika Kawabata; Takurou Matsubara; Makoto Tsubomoto; Yoshio Minabe; David A Lewis; Takanori Hashimoto
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

Review 7.  Perisomatic inhibition and cortical circuit dysfunction in schizophrenia.

Authors:  David A Lewis; Kenneth N Fish; Dominique Arion; Guillermo Gonzalez-Burgos
Journal:  Curr Opin Neurobiol       Date:  2011-06-15       Impact factor: 6.627

8.  Linking anatomical and physiological markers of auditory system degeneration with behavioral hearing assessments in a mouse (Mus musculus) model of age-related hearing loss.

Authors:  Anastasiya Kobrina; Katrina M Schrode; Laurel A Screven; Hamad Javaid; Madison M Weinberg; Garrett Brown; Ryleigh Board; Dillan F Villavisanis; Micheal L Dent; Amanda M Lauer
Journal:  Neurobiol Aging       Date:  2020-08-26       Impact factor: 4.673

Review 9.  Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.

Authors:  Patrizia Malaspina; Matthew J Picklo; C Jakobs; O Carter Snead; K Michael Gibson
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

10.  Genetic deficiency of GABA differentially regulates respiratory and non-respiratory motor neuron development.

Authors:  Matthew J Fogarty; Karen L Smallcombe; Yuchio Yanagawa; Kunihiko Obata; Mark C Bellingham; Peter G Noakes
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.